2 Einträge gefunden

1. Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

   1. Fiedler, Walter
   2. Stoeger, Herbert
   3. Perotti, Antonella
   4. Gastl, Guenther
   5. Weidmann, Jens
   6. Dietrich, Bruno
   7. Baumeister, Hans

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

   1. Fiedler, Walter
   2. Cresta, Sara
   3. Schulze-Bergkamen, Henning
   4. De Dosso, Sara
   5. Weidmann, Jens
   6. Tessari, Anna
   7. Baumeister, Hans

   2018 - Forschungsinformationssystem des UKE - frei zugänglich